Leveraging 3D Printing Capacity in Times of Crisis: Recommendations for COVID-19 Distributed Manufacturing for Medical Equipment Rapid Response.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
27 Jun 2020
Historique:
received: 27 05 2020
revised: 18 06 2020
accepted: 24 06 2020
entrez: 2 7 2020
pubmed: 2 7 2020
medline: 9 7 2020
Statut: epublish

Résumé

The SARS-CoV-2 (COVID-19) pandemic has provided a unique set of global supply chain limitations with an exponentially growing surge of patients requiring care. The needs for Personal Protective Equipment (PPE) for hospital staff and doctors have been overwhelming, even just to rule out patients not infected. High demand for traditionally manufactured devices, challenged by global demand and limited production, has resulted in a call for additive manufactured (3D printed) equipment to fill the gap between traditional manufacturing cycles. This method has the unique ability to pivot in real time, while traditional manufacturing may take months to change production runs. 3D printing has been used to produce a variety of equipment for hospitals including face shields, masks, and even ventilator components to handle the surge. This type of rapid, crowd sourced, design and production resulted in new challenges for regulation, liability, and distribution. This manuscript reviews these challenges and successes of additive manufacturing and provides a forward plan for hospitals to consider for future surge events. Recommendations: To accommodate future surges, hospitals and municipalities should develop capacity for short-run custom production, enabling them to validate new designs. This will rapidly increase access to vetted equipment and critical network sharing with community distributed manufacturers and partners. Clear guidance and reviewed design repositories by regulatory authorities will streamline efforts to combat future pandemic waives or other surge events.

Identifiants

pubmed: 32605098
pii: ijerph17134634
doi: 10.3390/ijerph17134634
pmc: PMC7370126
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Références

Acad Radiol. 2020 Jun;27(6):905-906
pubmed: 32335004
J Clin Microbiol. 2020 May 11;:
pubmed: 32393482
JAMA. 2014 Dec 3;312(21):2213-4
pubmed: 25461994
N Engl J Med. 2020 Apr 30;382(18):e41
pubmed: 32212516
J Med Virol. 2020 Mar 31;:
pubmed: 32232986
P T. 2014 Oct;39(10):704-11
pubmed: 25336867
Am J Med. 2020 Jul;133(7):771-773
pubmed: 32330492
Int J Environ Res Public Health. 2019 May 10;16(9):
pubmed: 31083479
Int J Oral Maxillofac Surg. 2020 May;49(5):673-677
pubmed: 32265088
Ann Occup Hyg. 2008 Jul;52(5):385-96
pubmed: 18477653
J Med Virol. 2020 Apr 8;:
pubmed: 32267002

Auteurs

Albert Manero (A)

Limbitless Solutions, University of Central Florida, 4217 E Plaza Drive, Orlando, FL 32816, USA.

Peter Smith (P)

Limbitless Solutions, University of Central Florida, 4217 E Plaza Drive, Orlando, FL 32816, USA.

Amanda Koontz (A)

Department of Sociology, University of Central Florida, 4000 Central Florida Blvd, Orlando, FL 32816, USA.

Matt Dombrowski (M)

Limbitless Solutions, University of Central Florida, 4217 E Plaza Drive, Orlando, FL 32816, USA.

John Sparkman (J)

Limbitless Solutions, University of Central Florida, 4217 E Plaza Drive, Orlando, FL 32816, USA.

Dominique Courbin (D)

Limbitless Solutions, University of Central Florida, 4217 E Plaza Drive, Orlando, FL 32816, USA.

Albert Chi (A)

Division of Trauma, Critical Care & Acute Care Surgery, Department of Surgery, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH